The application and integration of the best available research, clinical expertise, quality marks and patient preferences to ensure high-quality care in substance use disorders services.
Quality Assurance
Building Resilience and Bouncing Back from setback in Recovery: The PEER Perspective
ISSUP Malaysia are pleased to present their Webinar on Building Resilience and Bouncing Back from setback in Recovery: The PEER Perspective.
International treatment quality standards and what our treatment and rehab centers need to embrace
Join ISSUP Uganda for an event on International standards on treatment and what our health, social workers and centre managers can do to provide a minimum treatment and care standards for young people.
Profiles of quality of outpatient care use, associated sociodemographic and clinical characteristics, and adverse outcomes among patients with substance-related disorders
Abstract Background This study identified patient profiles in terms of their quality of outpatient care use, associated sociodemographic and clinical characteristics, and adverse outcomes based on frequent emergency department (ED) use...
Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder
Introduction There is increasing interest and evidence for the use of cannabinoid medications in the treatment of cannabis use disorder, but little examination of the correlates of successful treatment. This paper is a secondary analysis of...
Black girls and referrals: racial and gender disparities in self-reported referral to substance use disorder assessment among justice-involved children
Background There is a higher prevalence of substance use disorder (SUD) among justice-involved children (JIC). It is critical to ensure that JIC who report current use are referred for SUD assessment and potentially life-saving treatment...
Disruptions to U.S. local public health’s role in population-based substance use prevention and response during COVID-19
Background COVID-19 dramatically limited the scale and scope of local health department (LHD) work, redirecting resources to the response. However, the need for essential public health services—including substance use prevention—was not...
Experiences of frontline healthcare workers and their views about support during COVID-19 and previous pandemics: a systematic review and qualitative meta-synthesis
Background Healthcare workers across the world have risen to the demands of treating COVID-19 patients, potentially at significant cost to their own health and wellbeing. There has been increasing recognition of the potential mental health...
Supporting Government of Pakistan’s in its efforts to ensure standardized, adequate, and evidence-based drug dependence treatment and care
UNODC in collaboration with the Ministry of Narcotics Control (MoNC) and the Ministry of National Health Services Regulation and Coordination (MoNHSR&C) and with the generous support from US/INL, is developing National Standards and...
National policymakers and key stakeholders in Kyrgyzstan enhance their knowledge on drug use disorder system Quality Assurance through UNODC training
The UNODC Regional Office for Central Asia (ROCA) conducted a National Training “UNODC Drug Use Disorder Treatment Systems Quality Assurance (QA)” which took place in Bishkek, Kyrgyzstan on 28-30 November 2022. This capacity building...
INL DDR Partners Call - Quality Assurance
This month on November 9th, 2022, the International Narcotics and Law Enforcement Affairs (INL) DDR Partners meeting offered a discussion on quality assurance and included two presentations: Building Quality Improvement for SUD Treatment...